MacroGenics | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AbbVie USD 18M 0 2024-12
Amgen USD 33.53B 140M 2024-12
AstraZeneca USD 388M 0 2024-12
Biogen USD 100K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Daiichi Sankyo JPY 50B 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Genmab DKK 66M 0 2024-12
Geron USD 606K 3K 2024-12
Gilead Sciences USD 1000K 0 2024-12
J&J USD 3.12B 0 2024-12
MacroGenics USD 627K 0 2024-09
Merck USD 1.79B 0 2024-12
Pfizer USD 480M 0 2024-12
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Roche Holding CHF 107M 0 2024-06
Xencor USD 703K 2K 2024-12



MacroGenics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.